Form 8-K - Current report:
SEC Accession No. 0001789769-25-000003
Filing Date
2025-01-14
Accepted
2025-01-14 07:05:26
Documents
15
Period of Report
2025-01-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20250114.htm   iXBRL 8-K 31955
2 EX-99.1 pr8-kpressrelease.htm EX-99.1 11417
6 LOGO image_0.jpg GRAPHIC 2895
  Complete submission text file 0001789769-25-000003.txt   178142

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20250114.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20250114_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20250114_pre.xml EX-101.PRE 13038
17 EXTRACTED XBRL INSTANCE DOCUMENT til-20250114_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 25527743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)